The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
8.84
+0.12 (1.38%)
At close: Jan 2, 2026, 4:00 PM EST
8.85
+0.01 (0.11%)
After-hours: Jan 2, 2026, 4:10 PM EST
The Joint Market Cap
The Joint has a market cap or net worth of $131.42 million as of January 2, 2026. Its market cap has decreased by -20.40% in one year.
Market Cap
131.42M
Enterprise Value
103.96M
1-Year Change
-20.40%
Ranking
Category
Stock Price
$8.84
Market Cap Chart
Since November 11, 2014, The Joint's market cap has increased from $60.30M to $131.42M, an increase of 117.94%. That is a compound annual growth rate of 7.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 129.60M | -18.64% |
| Dec 31, 2024 | 159.30M | 12.34% |
| Dec 29, 2023 | 141.80M | -30.18% |
| Dec 30, 2022 | 203.10M | -78.55% |
| Dec 31, 2021 | 946.80M | 156.79% |
| Dec 31, 2020 | 368.70M | 64.75% |
| Dec 31, 2019 | 223.80M | 95.80% |
| Dec 31, 2018 | 114.30M | 70.34% |
| Dec 29, 2017 | 67.10M | 99.11% |
| Dec 30, 2016 | 33.70M | -42.98% |
| Dec 31, 2015 | 59.10M | -4.68% |
| Dec 31, 2014 | 62.00M | 2.82% |
| Nov 11, 2014 | 60.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |